A detailed history of Corbenic Partners LLC transactions in Pfizer Inc stock. As of the latest transaction made, Corbenic Partners LLC holds 165,745 shares of PFE stock, worth $4.43 Million. This represents 2.29% of its overall portfolio holdings.

Number of Shares
165,745
Previous 164,776 0.59%
Holding current value
$4.43 Million
Previous $8.53 Million 1.88%
% of portfolio
2.29%
Previous 1.85%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 25, 2022

BUY
$46.53 - $55.17 $45,087 - $53,459
969 Added 0.59%
165,745 $8.69 Million
Q1 2022

Apr 14, 2022

BUY
$45.75 - $56.69 $258,807 - $320,695
5,657 Added 3.56%
164,776 $8.53 Million
Q4 2021

Jan 21, 2022

BUY
$41.32 - $61.25 $335,972 - $498,023
8,131 Added 5.39%
159,119 $9.4 Million
Q3 2021

Oct 13, 2021

SELL
$39.25 - $50.42 $255,556 - $328,284
-6,511 Reduced 4.13%
150,988 $6.49 Million
Q2 2021

Jul 21, 2021

BUY
$35.91 - $40.68 $229,105 - $259,538
6,380 Added 4.22%
157,499 $6.17 Million
Q1 2021

Apr 14, 2021

BUY
$33.49 - $37.77 $879,413 - $991,802
26,259 Added 21.03%
151,119 $5.48 Million
Q4 2020

Jan 29, 2021

BUY
$33.47 - $42.56 $49,803 - $63,329
1,488 Added 1.21%
124,860 $4.6 Million
Q3 2020

Oct 09, 2020

SELL
$31.75 - $37.25 $920 - $1,080
-29 Reduced 0.02%
123,372 $4.53 Million
Q2 2020

Jul 17, 2020

SELL
$30.12 - $36.54 $8,162 - $9,902
-271 Reduced 0.22%
123,401 $4.04 Million
Q1 2020

Apr 16, 2020

BUY
$27.03 - $38.62 $479,268 - $684,771
17,731 Added 16.74%
123,672 $4.04 Million
Q4 2019

Jan 14, 2020

BUY
$32.92 - $37.36 $1.19 Million - $1.35 Million
36,216 Added 51.94%
105,941 $4.15 Million
Q4 2017

Jan 25, 2018

SELL
$33.26 - $35.29 $16,097 - $17,080
-484 Reduced 0.69%
69,725 $2.53 Million
Q3 2017

Oct 26, 2017

SELL
$31.0 - $34.15 $61,473 - $67,719
-1,983 Reduced 2.75%
70,209 $2.51 Million
Q2 2017

Aug 14, 2017

BUY
N/A
72,192
72,192 $2.43 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Corbenic Partners LLC Portfolio

Follow Corbenic Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corbenic Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corbenic Partners LLC with notifications on news.